MGNX – Macrogenics Inc
Float Short %
6.95
Margin Of Safety %
Put/Call OI Ratio
0.3
EPS Next Q Diff
0.42
EPS Last/This Y
-0.64
EPS This/Next Y
-1.07
Price
1.69
Target Price
3.75
Analyst Recom
2.5
Performance Q
6.96
Relative Volume
1.21
Beta
1.63
Ticker: MGNX
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-07-25 | MGNX | 1.72 | 0.15 | 0.20 | 4559 |
2025-07-28 | MGNX | 1.685 | 0.15 | 4.00 | 4579 |
2025-07-29 | MGNX | 1.59 | 0.16 | 0.00 | 4604 |
2025-07-30 | MGNX | 1.55 | 0.16 | 1.37 | 4599 |
2025-07-31 | MGNX | 1.57 | 0.24 | 0.00 | 5200 |
2025-08-01 | MGNX | 1.58 | 0.24 | 0.00 | 5180 |
2025-08-04 | MGNX | 1.635 | 0.24 | 0.00 | 5179 |
2025-08-05 | MGNX | 1.695 | 0.24 | 0.00 | 5183 |
2025-08-06 | MGNX | 1.62 | 0.24 | 0.00 | 5196 |
2025-08-07 | MGNX | 1.61 | 0.24 | 6.00 | 5296 |
2025-08-08 | MGNX | 1.545 | 0.24 | 0.00 | 5308 |
2025-08-11 | MGNX | 1.465 | 0.24 | 0.57 | 5286 |
2025-08-12 | MGNX | 1.475 | 0.25 | 20.00 | 5303 |
2025-08-13 | MGNX | 1.67 | 0.22 | 0.00 | 5205 |
2025-08-14 | MGNX | 1.615 | 0.22 | 0.00 | 5205 |
2025-08-15 | MGNX | 1.575 | 0.22 | 0.02 | 5205 |
2025-08-18 | MGNX | 1.525 | 0.32 | 0.00 | 2148 |
2025-08-19 | MGNX | 1.495 | 0.31 | 0.00 | 2182 |
2025-08-20 | MGNX | 1.49 | 0.30 | 999.99 | 2170 |
2025-08-21 | MGNX | 1.445 | 0.29 | 1.67 | 2168 |
2025-08-22 | MGNX | 1.685 | 0.30 | 0.00 | 2184 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-07-25 | MGNX | 1.71 | 142.7 | - | -0.63 |
2025-07-28 | MGNX | 1.69 | 142.7 | - | -0.63 |
2025-07-29 | MGNX | 1.58 | 142.7 | - | -0.63 |
2025-07-30 | MGNX | 1.54 | 142.7 | - | -0.63 |
2025-07-31 | MGNX | 1.56 | 142.7 | - | -0.63 |
2025-08-01 | MGNX | 1.58 | 142.7 | - | -0.63 |
2025-08-04 | MGNX | 1.64 | 142.7 | - | -0.63 |
2025-08-05 | MGNX | 1.69 | 142.7 | - | -0.63 |
2025-08-06 | MGNX | 1.62 | 142.7 | - | -0.63 |
2025-08-07 | MGNX | 1.61 | 142.7 | - | -0.63 |
2025-08-08 | MGNX | 1.54 | 142.7 | - | -0.63 |
2025-08-11 | MGNX | 1.47 | 142.7 | - | -0.63 |
2025-08-12 | MGNX | 1.48 | 142.7 | - | -0.63 |
2025-08-13 | MGNX | 1.66 | 142.7 | - | -0.63 |
2025-08-14 | MGNX | 1.61 | 142.7 | - | -0.63 |
2025-08-15 | MGNX | 1.57 | 142.7 | - | -0.63 |
2025-08-18 | MGNX | 1.52 | 142.7 | - | -0.63 |
2025-08-19 | MGNX | 1.49 | 142.7 | - | -0.63 |
2025-08-20 | MGNX | 1.49 | 142.7 | - | -0.63 |
2025-08-21 | MGNX | 1.44 | 142.7 | - | -0.63 |
2025-08-22 | MGNX | 1.69 | -136.7 | - | -1.71 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-07-25 | MGNX | -0.01 | -5.00 | 7.03 |
2025-07-28 | MGNX | -0.01 | -12.66 | 7.03 |
2025-07-29 | MGNX | -0.01 | -12.66 | 7.03 |
2025-07-30 | MGNX | -0.01 | -12.66 | 7.03 |
2025-07-31 | MGNX | -0.01 | -12.66 | 7.03 |
2025-08-01 | MGNX | -0.01 | -12.66 | 7.03 |
2025-08-04 | MGNX | -0.01 | -12.38 | 7.03 |
2025-08-05 | MGNX | -0.01 | -12.38 | 7.03 |
2025-08-06 | MGNX | -0.01 | -12.38 | 7.03 |
2025-08-07 | MGNX | -0.01 | -12.38 | 7.03 |
2025-08-08 | MGNX | -0.01 | -12.38 | 7.03 |
2025-08-11 | MGNX | -0.01 | -12.42 | 7.03 |
2025-08-12 | MGNX | -0.01 | -12.42 | 6.98 |
2025-08-13 | MGNX | -0.01 | -12.42 | 6.98 |
2025-08-14 | MGNX | -0.01 | -12.42 | 6.98 |
2025-08-15 | MGNX | -0.01 | -12.42 | 6.98 |
2025-08-18 | MGNX | -0.01 | -19.75 | 6.97 |
2025-08-19 | MGNX | -0.01 | -19.75 | 6.60 |
2025-08-20 | MGNX | 0.00 | -19.75 | 6.60 |
2025-08-21 | MGNX | 5.38 | -19.75 | 6.95 |
2025-08-22 | MGNX | 2.02 | -19.75 | 6.95 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.57
Avg. EPS Est. Current Quarter
-0.33
Avg. EPS Est. Next Quarter
-0.15
Insider Transactions
2.02
Institutional Transactions
-19.75
Beta
1.63
Average Sales Estimate Current Quarter
28
Average Sales Estimate Next Quarter
33
Fair Value
Quality Score
38
Growth Score
47
Sentiment Score
17
Actual DrawDown %
95.4
Max Drawdown 5-Year %
-97
Target Price
3.75
P/E
Forward P/E
PEG
P/S
0.65
P/B
2.29
P/Free Cash Flow
EPS
-0.57
Average EPS Est. Cur. Y
-1.71
EPS Next Y. (Est.)
-2.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-21.99
Relative Volume
1.21
Return on Equity vs Sector %
-102.8
Return on Equity vs Industry %
-89.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.05
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 341
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
stock quote shares MGNX – Macrogenics Inc Stock Price stock today
news today MGNX – Macrogenics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MGNX – Macrogenics Inc yahoo finance google finance
stock history MGNX – Macrogenics Inc invest stock market
stock prices MGNX premarket after hours
ticker MGNX fair value insiders trading